...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Annual Financial Reporting
4
Mar 22, 2024 12:55PM
1
Mar 22, 2024 03:10PM

At first I was going by the 45 days rule for interim reporting . But Zenith may not fall under it being on the OTC.

Anxious to know HL's intention. Renew or convert. Tic Toc!

 

Koo

1
Mar 22, 2024 04:17PM
1
Mar 22, 2024 04:57PM
1
Mar 22, 2024 05:43PM
2
Mar 23, 2024 10:17AM
1
Mar 23, 2024 06:16PM
1
Mar 23, 2024 07:48PM
3
Mar 23, 2024 08:04PM
1
Mar 23, 2024 08:21PM
Share
New Message
Please login to post a reply